Back to search

Netherlands· NL-c4fda9c4bd84

Cisordinol 10 mg, filmomhulde tabletten

A zuclopenthixol product containing zuclopentixoldihydrochloride, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC N05AF05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCisordinol 10 mg, filmomhulde tablett…ATCN05AF05REGISTER NO.NL-c4fda9c4bd84PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Zuclopenthixol is registered in 14 of 19 countries.

Countries holding a registration under ATC N05AF05 (zuclopenthixol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Zuclopenthixol · ATC N05AF05

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zuclopenthixol costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Zuclopenthixol · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZUCLOPENTIXOLDIHYDROCHLORIDE
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
N05AF05
ATC class
Zuclopenthixol
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    119731//04295

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for zuclopenthixol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zuclopenthixol · interactions on record

70 records

70 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Zuclopenthixol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zuclopenthixol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Cisordinol, Cisordinol Acutard
  • Belgium · Clopixol, Clopixol Acutard
  • Bulgaria · Клопиксол, Клопиксол-Акюфейз
  • Czechia · Cisordinol, Cisordinol-Acutard
  • Germany · Ciatyl-Z, Ciatyl-Z Acuphase
  • Denmark · Cisordinol, Cisordinol-Acutard
  • Estonia · Cisordinol, Cisordinol-Acutard
  • Spain · Clopixol, Clopixol Acufase
  • Finland · Cisordinol, Cisordinol-Acutard
  • France · Clopixol, Clopixol A Action Semi-Prolongee
  • United Kingdom (Northern Ireland) · Clopixol, Clopixol-Acuphase
  • Greece · Clopixol, Clopixol Acutard
  • Hungary · Cisordinol, Cisordinol-Acutard
  • Ireland · Clopixol
  • Iceland · Cisordinol, Cisordinol-Acutard
  • Italy · Clopixol
  • Lithuania · Cisordinol, Cisordinol-Acutard
  • Luxembourg · Clopixol, Clopixol Acutard
  • Latvia · Cisordinol, Cisordinol-Acutard
  • Norway · Cisordinol, Cisordinol-Acutard
  • Poland · Clopixol, Clopixol Acuphase
  • Portugal · Cisordinol Acutard
  • Romania · Clopixol
  • Sweden · Cisordinol, Cisordinol-Acutard
  • Slovenia · Clopixol, Clopixol-Acuphase
  • Slovakia · Cisordinol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bef489ba-90ad-4edf-9be3-e84fd5a920b2
GET /v1/drugs/bef489ba-90ad-4edf-9be3-e84fd5a920b2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h04295_smpc.pdf",
  "strength": null,
  "atc_label": "Zuclopenthixol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119731",
  "excipients": [
    "AARDAPPELZETMEEL",
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOVIDON (E 1208)",
    "GLYCEROL (E 422)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ZUCLOPENTIXOLDIHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119731.pdf",
  "authorised_at": "2016/12/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119731//04295",
  "additional_monitoring": "N"
}

See everything about zuclopenthixol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.